Dr. Stephen Badylak, DVM, PhD, MD is a Professor in the Department of Surgery, and deputy director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh.
Dr. Badylak has practiced both veterinary and human medicine, and is now fully engaged in research. Dr. Badylak began his academic career at Purdue University in 1983, and subsequently held a variety of positions including service as the Director of the Hillenbrand Biomedical Engineering Center from 1995-1998.
Dr. Badylak holds over 50 U.S. patents, 200 patents worldwide, has authored more than 300 scientific publications and 40 book chapters. He has served as the Chair of several study sections at the National Institutes of Health (NIH), and is currently a member of the College of Scientific Reviewers for NIH. Dr. Badylak has either chaired or been a member of the Scientific Advisory Board to several major medical device companies. More than four million patients have been treated with bioscaffolds developed in Dr. Badylak’s laboratory.
Dr. Badylak is a Fellow of the American Institute for Medical and Biological Engineering, a member of the Society for Biomaterials, a charter member of the Tissue Engineering Society International, the immediate past president of the Tissue Engineering Regenerative Medicine International Society (TERMIS) and a Founding International Fellow of TERMIS.
Dr. Badylak’s major research interests include:
• Naturally Occurring Biomaterials, including Extracellular Matrix, and Biomaterial/Tissue interactions
• Developmental Biology and its Relationship to Regenerative Medicine
• Relationship of the Innate Immune Response to Tissue Regeneration
• Biomedical Engineering as it Relates to Device Development and Biomaterials
• Clinical Translation of Regenerative Medicine
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.